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Abstract   
Cognitive Behavioural Therapy (CBT) is a form of evidence-based talking therapy 
that emphasises the importance of behaviour and conscious thoughts in shaping 
our emotional experiences. As pain becomes increasingly accepted as not only a 
sensory but also an emotional experience, success in using CBT to treat 
emotional disorders has resulted in the incorporation of cognitive-behavioural 
principles into the management of chronic pain. Outcomes of CBT-informed 
interdisciplinary pain management programmes are modest at best, despite 
rapid methodological improvements in trial design and implementation. Whilst 
the field searches for new treatment directions, a hybrid CBT approach that 
seeks to simultaneously tackle pain and its comorbidities shows promise in 
optimising treatment effectiveness and flexibility.  This article provides a brief 
description of the core characteristics of CBT and the transformation this 
therapeutic model has brought to our understanding and management of chronic 
pain. Current evidence on efficacy of CBT for chronic pain is then reviewed, 
followed by a critical consideration of the advantages and disadvantages of the 
new hybrid treatment approach that conceptualises and treats chronic pain in 
connection with its comorbidities. Recent progress made in the area of pain and 
insomnia is highlighted as an example to project therapeutic innovations in the 
near future. 
 
 
Keywords 
CBT, insomnia, chronic pain, psychological treatment, pain management, hybrid 
CBT, combined treatment.  
 
 
 
Highlights  
1. CBT emphasises the role of behaviour and conscious thoughts in shaping 
our emotional experiences 
 
2. Success in using CBT to treat emotional disorders has led to its 
application in chronic pain, a sensory and emotional experience.  
 
3. Effects of interdisciplinary pain management programmes based on CBT 
principles are however modest…  
 
4. …and relatively weak compared to the effects achieved by CBT for 
emotional disorders 
 
5. A hybrid CBT that simultaneously tackles chronic pain and its 
comorbidities is proposed as an alternative approach to optimise 
treatment effect.  
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1. What is Cognitive-Behavioural Therapy? 
After decades of research and dissemination, cognitive-behavioural therapy 
(CBT) is now a household name synonymous with psychological treatment for 
health and wellbeing in developed countries (1, 2). CBT stands for a form of 
talking therapy that emphasises the importance of both behaviour and conscious 
thoughts in shaping our emotional experiences (3-6). Its theoretical foundation 
extends from the purely behavioural learning principles (e.g., classical and 
operant conditioning), to incorporate cognitive factors (e.g., beliefs and 
attribution) in recognition of their roles in influencing our behaviour, affecting 
how we feel, and even shaping our physiological responses.  
 
Typically, psychological interventions that draw on both behavioural principles 
and cognitive science – regardless of the extent – are collectively referred to as 
CBT. Hence, CBT is an umbrella term that includes treatments of different foci, 
contents, designs, length and interface. Several key features should, however, be 
recognisable even across different permutations of CBT (5). First, in contrast to 
psychodynamic approaches, CBT focuses on the conscious experience and the 
here-and-now. The aim of the treatment is to help the patient bring about 
adaptive learning and desirable changes in their present lives, not their distant 
past. And so relatedly, second, the treatment content of CBT is goal-driven; and 
duration time-limited. Third, a large part of the treatment is about problem-
solving and acquisition of new coping skills. Consolidation of learning between 
treatment sessions in the form of an exercise or a homework assignment is 
important, as these are the tools to help the patient apply and generalise their 
new skills to contexts outside of the therapy setting. The ultimate goal is to 
enable the patient to become their own therapist, and hence, fourth, the 
therapeutic relationship shared between the CBT therapist and the patient is 
collaborative and supportive, rather than hierarchical and directive. Finally, in 
keeping with the tradition of scientific investigation of human behaviour and 
cognition, CBT as a field places strong emphasis on defining concepts in 
measurable terms and putting treatment programmes under the scrutiny of 
empirical evaluation, ranging from single-case experiments to multi-centre 
randomised controlled trials. Such tradition lays the foundation of the evidence-
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based nature of CBT; and the corresponding training of CBT delivery can be 
distinguished from that for non-directive counseling, which puts heavier 
emphasis on conversation and empowerment within a social and cultural 
context and lighter emphasis on symptom reduction and treatment process and 
outcome evaluation. 
 
The emergence of CBT was originally embedded within the growing need to 
address common emotional disturbances such as anxiety and depression (3, 7, 8) 
but its influence soon spread and led to successful applications in the 
understanding and treatment of a range of difficult-to-treat psychiatric and 
medical disorders. These include panic disorder, obsessive-compulsive disorder, 
posttraumatic disorder, health anxiety, eating disorders, insomnia disorder, 
schizophrenia, and suicide. Chronic pain is a prevalent, disabling condition 
affecting 19% of the general population in Europe (9) and as many as 31% of the 
adult population in the US (10). It is one of the areas that has benefited from the 
application of CBT principles for the understanding and management the 
condition. Below I will illustrate the emergence of CBT for chronic pain, 
beginning with a brief overview of the development in pain conceptualisation 
that has led to the application of interventions based on cognitive-behavioural 
principles and further work in evaluating the efficacy of CBT pain management 
programmes. 
 
2. CBT in Pain 
2.1. Theoretical developments 
Pain was once thought to be a strictly biological phenomenon that is specifically 
and proportionally linked to tissue damage or an underlying pathology. 
However, a shift in thinking was marked by the introduction of the 
groundbreaking Gate Control Theory (11), which attempts to explain well-
documented anomalies that deviate from previous conceptualisations of pain, 
such as the highly variable relationship between injury and pain, whereby 
innocuous stimuli may produce pain and that pain may persist or even spread in 
the absence of injury or after an extensive period of healing. In layman’s terms, 
the Gate Control Theory describes how nerve impulses enter the spinal cord and 
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travel to the brain for interpretation as pain. Transmission of the signals can go 
in both the top-down and bottom-up directions, and a gating mechanism in the 
dorsal horn of the spinal cord functions to modulate the signals, such that whilst 
the balance of the small and large fibre activities in the spinal cord can facilitate 
(i.e., open the gate) or inhibit (i.e., close the gate) the afferent signals, the brain 
can send descending signals to modulate the transmission, exerting central 
control.  
 
Although the premises of the Gate Control Theory are fundamentally 
physiological, the theory offers a readily acceptable grounding for psychological 
explanations of variations in pain responses to flourish. In contrast to 
nociception, pain was subsequently recognised as a “psychological state”, when 
the International Association for the Study of Pain (IASP) put forward a 
taxonomical definition of pain as “an unpleasant sensory and emotional 
experience associated with actual or potential tissue damage, or described in 
terms of such damage” (12).  The IASP definition brings to the fore that pain is 
not just a sensory but also an emotional experience, subject to psychological 
influence.  
 
The shift away from the strictly physiological approach to pain has permitted the 
application of behavioural and cognitive principles for the study and 
management of pain. This was spearheaded by the work of Fordyce (13, 14) who 
detailed how adaptive acute pain behaviour (e.g., grimace, moaning, limping, 
avoidance of activity, increased use of anagelsics) is reinforced and maintained 
to become maladaptive and chronic by positive and negative reinforcement, in 
line with the generic operant conditioning model. Accordingly, it was suggested 
that chronic pain is best treated as a set of illness behaviour and the intervention 
should be focused on modifying the environment contingencies that elicit the 
pain behavior, with a goal to reduce their frequency of occurrence and hence the 
associated disability (15).  
 
Subsequent research into the effect of cognition (pain catastrophising, pain 
anticipation, pain memory) and affect (anxiety, depression) on pain perception 
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and coping has led to the incorporation of a cognitive dimension into the 
primarily behavioural approach to chronic pain (16). Several iterations of the 
fear-avoidance model of chronic pain have been proposed to explain how 
different interpretations of the same pain experience could determine whether a 
person would confront the pain and be on the road of recovery, or display the 
chronic pain behaviour that would eventually lead to disuse, depression and 
disability (17-23). There are subtle differences in the emphasis of each iteration 
of the fear-avoidance model, but the key cognitive factors at play is the 
interpretation and meaning people ascribe to the pain experience. In the absence 
of serious pathology, if the pain is considered unpleasant but non-threatening, 
then the person would perhaps restrict pain-provoking activity in the short term 
but gradually return to their prior level of activity as the injury heals up and pain 
dissipates. However, if pain is given a catastrophic meaning suggesting harm or 
threats to body integrity, the catastrophic meanings ascribed to the pain will give 
rise to pain-related fear, motivating hypervigilance (such as excessive threat-
monitoring behaviour) and behavioural avoidance (of daily activities that may 
induce or aggravate pain) in the long term (Figure 1a). Such conceptualisation of 
chronic pain and its associated distress and disability brings the theoretical 
development closer to the Beckian approach to CBT (Figure 1b) and the generic 
model of anxiety disorders (Figure 1c). Subsequent modifications to the model to 
consider the influence of negative affectivity, physiological arousal, and the role 
of threatening illness information expand the horizon of the examination to align 
more closely with the multidimensional perspective of pain and the PPP 
(predisposing, precipitating and perpetuating factors) case formulation 
framework (23). 
 
INSERT Figure 1 ABOUT HERE 
 
2.2.  Treatment implications 
Given that avoidant behavior and catastrophising are hypothesised to be key 
interacting mechanisms underpinning the development and maintenance of 
disability and disuse in chronic pain, a therapeutic intervention derived from the 
fear-avoidance model is graded exposure to movements and activities feared by 
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the patient. In contrast to graded activity that aims to increase the total amount 
of physical activity, the idea behind graded exposure in vivo is to afford the 
patient the opportunity to confront their fear. Through engaging in a series of 
behavioural experiments (24), the patient is also helped to disconfirm or soften 
prior expectations and catastrophic beliefs that movements will cause (re)injury 
and further suffering. Typically, the design of the exposure procedure is 
personalised to the patient’s individual fear hierarchy such that patients are first 
exposed to activities associated with mild to moderate levels of fear before 
confronting activities that provoke high levels of fear (25-27). Several high-
quality single case series and randomised controlled trials have demonstrated 
the effectiveness of graded exposure over and above psycho-education or graded 
activity in patients with chronic low back pain (25, 28-32), neck pain patients 
(33, 34), and complex regional pain syndrome (35), with concurrent reductions 
in pain-related fear, pain catastrophising and pain-related disability. The results 
also appeared to maintain well up to 6 months after treatment. 
 
Graded exposure in vivo, however, is not the sole intervention received by 
chronic pain patients, as psychological treatments tends to be delivered as part 
of an interdisciplinary pain management programme within specialist pain 
clinics (36, 37). Within such a context, CBT for chronic pain is much more 
broadly defined as an amalgamation of interventions that may vary in approach 
and emphasis (Behaviour Therapy, Cognitive Therapy, Cognitive-Behavioural 
Therapy, Acceptance Commitment Therapy), format (individual vs. group; 
outpatient vs. inpatient; face-to-face vs. telemedicine/online), and dosage 
(amount of input at different frequency and levels of intensity) depending on the 
availability of resources and expertise. The theoretical principle and evidence-
base of these other treatment components, arguably, are not always as well 
documented as graded exposure. 
 
Nonetheless, the central goal of most pain management programmes based on 
cognitive-behavioural principles is to help patients better manage problems 
evolved around maladaptive emotions, cognition and behaviour, rather than 
focusing on pain elimination. Like CBT for depression and anxiety, main 
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components of CBT for chronic pain include first and foremost psycho-education, 
which involves educating the patients about the rationale of the treatment and 
the impact of cognition and behaviour on their emotions and pain experience. 
Once a shared understanding of the CBT model of chronic pain is estabilshed, the 
patients will be taken through a journey of coping skills training ranging from 
relaxation, physical exercise, pacing, to communication skills training. The idea is 
that during the course of the treatment, the patients are helped to apply these 
skills in day-to-day situations and maintain these skills as they are practised in 
real life. Patients are also taught how to cope with relapse and flare-ups, in the 
hopes that they will become their own therapists when the therapeutic 
engagement comes to an end. Table 1 below outlines the aims and methods of 
several common CBT components often included in interdisciplinary pain 
management programmes. 
 
INSERT Table 1 ABOUT HERE 
 
2.3. Efficacy of CBT for chronic pain 
Notwithstanding the known heterogeneity in treatment content, CBT for chronic 
pain has typically been evaluated for its efficacy as an overall package in a 
number of RCTs. A comprehensive Cochrane Review by Eccleston, Williams, & 
Morley (39) has provided an excellent overview of the efficacy of CBT for the 
management of chronic pain in general, except headache, among adult patients. 
Specifically, the systematic review and meta-analysis included 24 meta-analyses 
based on data pooled from 40 RCTs, published before Jan 2008 involving 4781 
participants (Mean age = 48.7 yrs; Median pain duration: 9.9 yrs). The purpose of 
the analyses was to examine the effect of BT and CBT versus passive or active 
treatment control interventions on pain, disability, and mood at post-treatment 
and at follow-up (6-12 months after treatment). In these analyses, passive 
treatment control interventions referred to control procedures in RCTs that 
were labeled as “waiting list control” or “treatment as usual”. Active treatment 
control interventions were those that involved a protocolised treatment that 
engaged the patients, e.g., a self-help booklet, a support group, an exercise class, 
an educational programme, or a medical procedure. Of the 6 outcome 
 9 
comparisons made for CBT against passive treatment control interventions, 2 
revealed a significant effect showing that CBT had a small effect on pain 
(Standardised Mean Difference = -0.19; 95% Confidence Interval: -0.32, -0.05; I2 
= 24%) at post-treatment and on mood (SMD = -0.16; 95% CI: -0.31, -0.01; I2 = 
0%) at follow-up. Similarly, of the 6 outcome comparisons made for CBT against 
active treatment control interventions, 4 revealed a significant effect showing 
that CBT had a small effect on disability (SMD = -0.16; 95% CI: -0.31, -0.02; I2 = 
0%) at post-treatment and on all 3 outcome measures at follow-up (Pain: SMD = 
-0.15; 95% CI: -0.28, -0.02; I2 = 0%. Disability: SMD = -0.21; 95% CI: -0.36, -0.06; 
I2 = 15%. Mood: SMD = -0.16; 95% CI: -0.29, -0.03; I2 = 0%). The quality of trials 
included was assessed qualitatively using the ‘high’, ‘unclear’ and ‘low ‘risk 
traffic light system and quantitatively using the Yates et al. scale (40). 
Qualitatively, the majority of the studies were considered to have ‘adequate’ 
study (65.4%), treatment (53.8%) and design (61.5%) quality. Quantitatively, 
the mean overall quality of the studies was 19.3 (Standard Deviation = 4.8; Range 
= 9-28). The mean design quality score was 14.4 (SD= 3.7; Range = 7-23) and the 
mean treatment quality score was 4.9 (SD= 2.2; Range = 1-8). 
 
As the number of RCTs of CBT for chronic pain has rapidly increased in a short 
space of time, Williams et al. (41) provided an update to the 2009 review 
involving 35 RCTs of 4788 participants published before September 2011. This 
review had similar but slightly more stringent inclusion criteria, raising the bar 
of entry from 10 to 20 participants in each treatment arm. This decision was to 
minimise potential risk of bias associated with trials of small sample size and to 
address the overall tendency for smaller or poor-quality trials to produce more 
positive results (42-44). A total of 65 trials were identified and 42 met inclusion 
criteria, of which 16 were new entries since the 2009 review and 35 of these 
trials provided data for the meta-analysis. The included studies showed an 
improvement in their overall methodological quality as expected. Using the same 
method of comparisons, the pattern of findings was broadly similar to those 
shown in the 2009 review (see Figure 2a & 2b). Although the longer term effect 
on pain and mood found for CBT against active treatment control interventions 
no longer upheld at follow up, the effects of CBT against passive treatment 
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control interventions were noticeably more consistent and appeared to be 
stronger across all 3 major outcome measures.  
 
INSERT Figure 2 ABOUT HERE 
 
Based on both sets of review, the authors concluded that there was a sufficiently 
large evidence base to show that CBT had a small to moderate beneficial effect 
on key outcome measures of importance to chronic pain, particularly at 
immediately after treatment and when compared to passive control 
interventions. The magnitude of the effect was not as big as hoped, but may 
accurately reflect the true extent of “complexity of behaviour change and the 
social and psychological influences that maintain disability in chronic pain 
patients” (45). Whilst there are many theoretical and practical issues remain to 
be addressed to move the field forward (see discussion of (41) for an insightful 
analysis), CBT can be useful in reducing pain, disability and psychological 
distress, in par with other established drug and physical treatments for chronic 
pain (46, 47).  
 
2.4. Challenges beyond perfecting RCT methodology 
Interested readers are referred to Williams et al., Morley et al., and Eccelston (48, 
49), for a detailed analysis on the theoretical and practical issues remained to be 
addressed by the field. Two additional challenges are highlighted below, as we 
consider the connections between CBT for chronic pain and CBT for other 
psychological disorders. 
  
First, despite the more consistent effect of CBT, the magnitude of the controlled 
effect size is small according to Cohen’s interpretation (1992) as well as relative 
to what can be achieved in CBT for other common emotional disorders (51), as 
summarised in Table 2.  Using mood - the most favourable outcome measure in 
the 2012 Cochrane review - for example, the maximum effect size was 0.38 
immediately after treatment but attenuated to 0.26 at follow-up. These statistics 
mean that a person randomly drawn from the CBT group has only a 61% chance 
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of being better off than a person randomly drawn from the passive control group 
(i.e., the probability of benefit) when the comparison is made at post-treatment; 
the probability of benefit reduces to 57% when the comparison is made at 6- to 
12- month follow-up. The deficits in effect size and probability of benefit evident 
in Table 2 raise the question that, perhaps, the field is far from maximising the 
potential of CBT for the management of chronic pain. It is also noted that, for 2 of 
the 3 key outcome measures (i.e., pain intensity and disability), the effect of CBT 
for chronic pain did not sustain at follow-up as it would normally be expected for 
CBT for common emotional disorders. This is surprising given the heavy skills 
learning component in various pain management packages.  
 
INSERT Table 2 ABOUT HERE 
 
Second, the overwhelming majority of the chronic pain patients seen in day-to-
day clinical practice are presented with some kind of physical or psychological 
comorbidity (52, 53). More often than not, those reporting comorbid issues are 
also those who reported more severe pain, greater disability, and poorer quality 
of life (54). Outside of the clinical setting, Von Korff and colleagues (2005) 
estimated that 87% of the general population living with chronic spinal pain also 
reported at least 1 other mental disorder, chronic physical diagnosis, and/or 
other chronic pain conditions. Importantly, the presence of these comorbidities 
explained approximately a third of the association between chronic pain and 
disability. Similar findings were reported by McWilliams and associates (2003) 
focusing on the co-occurrence of chronic pain with psychiatric disorders. 
Significant cross-sectional associations were observed between chronic pain and 
mood and anxiety disorders (odds ratios = 1.92  - 4.27), with the strongest 
associations being found for panic disorder (OR = 4.27) and post-traumatic 
stress disorder (OR = 3.69). Additionally, the presence of more than one 
comorbid psychiatric disorders was significantly linked to increased disability. 
Together, these findings converge to suggest that the purely pain-focused 
treatment approach may be inadequate for tackling the complex psychological 
issues experienced by chronic pain patients, which could be simultaneously be 
maintained by the pain and the co-existing comorbid physical and psychiatric 
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conditions. A radical reconceptualisation of our treatment approach to chronic 
pain is warranted if we were to break through the treatment effect size ceiling 
and to improve the quality of care to become more patient-centred, rather than 
diagnosis-focused.  
 
3. A hybrid approach 
A hybrid approach to the treatment of chronic pain is an exciting new direction, 
whereby the treatment is developed and applied to simultaneously address 
multiple issues linked to chronic pain rather than exclusively focusing in on pain 
management or reduction (57-59). The concept represents a departure from the 
conventional practice that confines the matching of interventions to well-defined 
diagnostic labels. It explicitly acknowledges that complex conditions, such as 
chronic pain, do not exist in isolation, but interacts with co-occurring physical 
and mental comorbidities that may in return impact on pain management.  
 
3.1. Advantages 
By adopting a broader conceptualisation of the distress and disability 
experienced by chronic pain, the hybrid approach gives clinicians the flexibility 
to draw up treatment and rehabilitation plans based on individual case 
formulations rather than relying on predetermined protocolised treatment 
packages. It also facilitates better customisation of treatment, an action point 
that has been called for by multiple leaders of the field (36, 39, 41, 48, 60). 
 
The hybrid treatment approach is arguably a more appropriate strategy for 
managing chronic pain, which by definition is intractable. Simultaneous efforts 
targeting common comorbidities offer new treatment entry points to break 
unhelpful patterns of pain-related cognition and behavior that give rise to the 
distress and disability. Instead of fixating on managing pain, a hybrid approach 
diversifies the treatment goal, allowing the patient to reframe their relationship 
with pain and offering the opportunity to move away from pain control and to 
focus their efforts on addressing other issues affecting quality of life and on 
attaining more achievable goals (61). It also opens up possibilities of introducing 
treatment components that target transdiagnostic processes, e.g., hypervigilance, 
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worry, catastrophising, appraisal biases, avoidance, safety-seeking behavior, and 
thought-suppression (62-64). The result of these changes may streamline the 
process of imparting core coping skills that are essential for wellbeing and 
optimal functioning, especially within the modern healthcare eco-system where 
time and resources are limited.  
 
Practically, the hybrid approach downplays the importance of establishing the 
‘primary’ and ‘secondary’ hierarchy of co-occurring disorders and helps to 
bypass the artificial boundary between physical and mental health. This is in line 
with shifts in thinking around comorbidities management (65-67) and can serve 
to simplify the navigation through complex health care pathways by offering 
treatment of multiple problems under one roof and reducing the number of 
contact points. It may also help to avoid situations in which patients are stuck in 
gaps between physical and mental health care services. It is not uncommon to 
hear of accounts of treatment seeking experience in which patients found 
themselves refused treatment by mental health services because the 
psychological symptoms were considered to be ‘caused’ by pain (thus the patient 
‘should’ be seen by pain specialists), or by pain management services because 
the psychological symptoms are thought to be too severe impacting on pain 
management efforts (and hence specialist psychological input ‘should’ be 
received first, before the patient is re-referred to the pain service for 
rehabilitation). 
 
3.2. Recent development in pain and insomnia as an example 
Although the overlaps between pain and anxiety (56, 68) and between pain and 
depression (69-71) are better recognised, the co-occurrence of pain and sleep 
has received more attention in recent years and witnessed a surge in research 
efforts in understanding the nature of comorbidity and in developing specific 
hybrid treatments for improving treatment efficacy and patient outcomes (57, 
72-75). The co-existing problem of sleep and pain is widespread. In the general 
population, around two-thirds of individuals living with chronic pain report a 
reduced ability to sleep because of their pain (9). At the more severe end of the 
spectrum, it has been estimated that between 50 and 90% of patients seeking 
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treatment from hospital pain clinics report insomnia of a severity that warrants 
clinical attention (76-78). Further, it is understood that chronic pain patients 
who experience insomnia are also those who report higher pain intensity, 
anxiety, depression, physical and psychosocial disability (9, 79-86). Left 
untreated, the majority of the insomnia cases would persist (87) continuing to 
undermine efforts of pain management and compound the level of pain, distress 
and disability. Such detrimental effect is observed both on a day-to-day basis 
(88-92) and over longer periods (93). 
 
The development of hybrid treatments for chronic pain and insomnia is only in 
its infancy, but it is certainly a movement gaining momentum at a time when the 
term ‘secondary insomnia’ is being phased out (94) and epidemiological 
evidence is accumulating to show that sleep is a risk factor and a potential cause 
of a range of physical and mental illnesses, directly and indirectly increasing the 
risk of mortality (95). The momentum is also bolstered by demands from the 
pain patients themselves, explicitly stating the negative impact on pain 
management when they are not sleeping well (96, 97) and indicating that their 
wish to receive more support and help in obtaining better sleep (9, 98, 99). 
These patient demands make a lot of sense, as increasing evidence has shown 
that sleep disruption can aggravate pro-inflammatory responses, amplify pain 
experience, weaken endogenous pain inhibitory control, reduce pain tolerance, 
and increase bodily symptoms (100-103). 
Yet, sleep thus far is not a main focus of many existing pain management 
programmes, although standard sleep hygiene advice - which is not considered 
as an effective stand-alone treatment for insomnia (104, 105) - is usually given to 
patients as part of the psychoeducation component of the intervention. 
Naturally, sleep is not a major outcome measure when evaluating the impact of 
these pain management programmes. Of the few trials that do measure sleep 
pre-and post-treatment, a couple of studies have demonstrated that sleep does 
not necessarily improve after completion of a course of CBT for pain, even when 
improvements are found for pain coping skills and pain-related functional 
outcomes (106, 107). A couple others have shown a slight improvement in 
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subjective ratings of sleep, but “against a backdrop of poor patterns of night time 
sleep” with no improvement in key quantitative sleep efficiency and quantity 
parameters (108, 109). In contrast, a series of RCTs evaluating the application of 
CBT for insomnia (CBT-I) in chronic pain patients have shown promise (57, 110, 
111). As summarised in a recent meta-analysis involving 11 RCTS involving 1066 
patients, psychological sleep treatments in chronic pain patients are associated 
with not only improvement in sleep quality; significant improvements were also 
found for pain and fatigue at post-treatment and for fatigue and depression at 
follow-up up to 12 months (112).  
Capitalising on these promises, in the last 5 years or so at least three different 
groups in the US and the UK have independently published initial findings 
evaluating the feasibility and utility of hybrid treatments for chronic pain and 
comorbid insomnia. Two pilot RCTs were conducted with mixed groups of 
chronic pain patients recruited from secondary care (58, 113) and one multi-
centre 3-arm RCTs was tested with older osteoarthritis patients from primary 
care (114-116). The timing of these publications clusters around the same time, 
reflecting a consensus that ‘going hybrid’ may be a promising direction for future 
treatment development. 
There are variations between these hybrid treatment programmes in term of the 
selection of treatment components. The hybrid treatment in Tang et al. (58) was 
designed to target cognitive-behavioural processes maintaining chronic pain and 
insomnia. The weekly treatment was delivered by psychologist on a one-to-one 
basis over 4 weeks. The selection of treatment components was informed by 
existing treatment manuals (117-119), systematic reviews on treatment 
effectiveness (39, 41, 120), and research on transdiagnostic processes 
maintaining these disorders (121-125). Equal emphasis was given to pain and 
sleep. The 8 treatment components included (i) sleep psycho-education, (ii) 
stimulus control, (iii) sleep restriction, (iv) cognitive therapy for insomnia, (v) 
individual pain formation, (vi) goal setting & behavioural activation, (vii) 
reducing pain catastrophising & safety-seeking behavior, and (viii) reversing 
mental defeat for the management of chronic pain. The intervention used in 
Pigeon et al. (113) was much more extensive and contained 16 elements 
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commonly seen in pain management and insomnia treatment packages. The 
intervention was delivered individually by psychologist over 10 weekly sessions. 
Specifically, the intervention included (i) pain psychophysiology education, (ii) 
relaxation training, (iii) pacing, (iv) pain-specific cognitive therapy, (v) activity 
planning, (vi) problem-solving, (vii) communication skills, and (viii) flare-up 
planning and relapse prevention for the management of chronic pain; (ix) sleep 
education, (x) sleep restriction, (xii) stimulus control, (xiii) sleep hygiene, (xiv) 
sleep-specific cognitive therapy, (xv) relaxation training, and (xvi) relapse 
prevention for the management of insomnia. Similarly, the combined treatment 
in Vitiello et al. (115) incorporated CBT-I components such as sleep hygiene 
education, stimulus control, sleep restriction and daily sleep monitoring into a 
standard programme of pain management with pain education, physical 
activation, goal setting, relaxation, activity pacing, guided imagery and cognitive 
restructuring. However, the treatment was more didactic in nature, delivered in 
classes of 5-12 patients over six weekly 90-minute sessions.   
Despite these differences, both Tang et al. (58) and Pigeon et al. (113) found 
their respective hybrid treatments produced significantly better results in not 
only sleep, but also mood, fatigue and pain-related outcomes compared to 
waitlist controls. Pitching against standard programmes of CBT for pain or 
insomnia per se, the hybrid intervention showed a huge advantage over CBT for 
pain on most outcomes and a small advantage over CBT for insomnia in reducing 
insomnia severity in chronic pain patients (113). These preliminary findings 
were upheld in the multi-centre RCTs by Vitiello et al. (115), in which the hybrid 
treatment logged the best outcome in reducing insomnia severity compared to 
both the education-only control and the CBT for pain groups. Although pain 
severity and arthritis outcomes did not differ among the 3 treatment arms, a 
subsequent secondary analysis using data across all groups revealed that long-
term (9- and 18-month) improvements on multiple measures of sleep, chronic 
pain, and fatigue were significantly predicted by short-term (2-month) 
improvements in sleep. These findings support the idea that sleep treatment can 
have a beneficial impact on pain and other aspects of wellbeing, even though 
these effects may take time to emerge. 
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3.3. Challenges and issues remained  
It appears as though the hybrid treatment approach has clear potential for 
enhancing treatment effectiveness of existing pain management programmes. 
Further replications would, however, be required to demonstrate reliability and 
generalisability across different subgroups of pain patients (e.g., musculoskeletal 
versus neuropathic versus inflammatory pain; regional versus diffuse pain) and 
treatment contexts (e.g., primary versus secondary care). It would be also 
important to rule out that the better outcomes associated with hybrid treatment 
over standard pain or insomnia treatment was not merely an artifact of the 
longer treatment duration, extended treatment content, or other confounders, 
such as researchers’ allegiance and enthusiasm, not controlled for in the 
aforementioned outcome studies.  
 
Whilst additional help with sleep was something specifically requested by 
patients for improving their management of chronic pain (9, 98, 99), it is unclear 
if the treatment experience has been found positive and beneficial by this patient 
group. None of the previous trials on hybrid pain and sleep treatment was 
published with an accompanying treatment process evaluation. To inform 
patient-centred care, future studies should consider including qualitative 
analyses as such to shed light on the acceptability of the new treatment 
approach. Additionally, qualitative feedback from treatment providers would be 
useful in terms of informing the therapist training, treatment delivery and 
dissemination processes, all of which are yet to be refined at this infancy stage of 
treatment development. Practical questions like “who with what training should 
be delivering the treatment in what dosage, format, and sequence?” and “where 
should we situate the service within the existing clinical care pathway to achieve 
optimal long-term cost-effectiveness?” need to be answered. Answers to these 
questions will have important implications for future research funding and 
service development. 
 
4. Conclusion 
The developing of a feasible hybrid treatment for pain and insomnia has taken 
advantage of the growing wealth of research evidence into the links and 
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association between the two conditions (72, 73). Given the equally fascinating 
links of pain with depression (52, 53), PTSD  (126-128), substance misuse (129-
131), obesity (132-135), to name but a few, the hybrid treatment approach could 
easily be adopted to provide more concentrated care in these areas depending 
on the patient’s need. This is especially relevant considering that, with a more 
refined understanding of the connections between these oft-seen comorbidities, 
a modular treatment design could be engineered to expand the breadth and 
flexibility of clinical service and enhance patients’ choice. The adoption of the 
hybrid treatment framework may even facilitate a more rapid transfer of 
theoretical and psychological treatment advances in the linked fields, stimulating 
innovations in the years to come.   
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